Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$18.63

0.01 (0.05%)

10:10
10/17/16
10/17
10:10
10/17/16
10:10

Far downside put buyers in Myriad Genetics

Far downside put buyers in Myriad Genetics. Small lots of Nov 15 puts trade across the exchanges for 10c each. 3K total and the bearish flow opens positions struck 22% below spot. Earnings 11/1.

MYGN Myriad Genetics
$18.63

0.01 (0.05%)

08/29/16
BOFA
08/29/16
NO CHANGE
BOFA
Myriad Genetics loses BCBS of Nevada contract to LabCorp, says BofA/Merrill
Analysts at BofA Merrill Lynch noted that Myriad Genetics (MYGN) has lost an in-network contract with Blue Cross Blue Shield of Nevada to LabCorp (LH) and the firm expects Myriad shares to trade down following the news. The firm sees the potential for a continuation of this trend across other BCBS systems in other states.
10/10/16
LTCO
10/10/16
DOWNGRADE
Target $16
LTCO
Sell
Myriad Genetics downgraded to Sell from Neutral at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter downgraded Myriad Genetics (MYGN) to Sell citing a "significant and unexpected deterioration" in outlook for the company's companion diagnostic franchise. The analyst expects a lower growth outlook to drive "significant P/E multiple compression." Tesaro (TSRO) presented data this weekend that suggested its PARP inhibitor niraparib was active in a maintenance setting for recurrent ovarian cancer in patients with either positive or negative HRD scores. The analyst had expected the drug to benefit only HRD positive patients. As such, the use of niraparib will not require HRD testing, DeGeeter tells investors in a research note. The analyst has a $16 price target for the shares.
10/10/16
PIPR
10/10/16
NO CHANGE
PIPR
Neutral
TESARO data suggest Myriad test not necessary, says Piper Jaffray
Piper Jaffray analyst William Quirk points out that data over the weekend from TESARO (TSRO), Myriad Genetics' (MYGN) companion diagnostic partner, suggest niraparib works in all-comers, making Myriad's test not necessary. Myriad shares may be down physiologically, Quirk tells investors in a research note partially titled "When A Partnership Produces Mixed Results." The analyst, however, believes niraparib is not clinically significant in HRD negative patients and that Myriad's test will be included on the drug label. He keeps a Neutral rating on shares of Myriad. Ladenburg Thalmann this morning downgraded the stock to Neutral.
10/10/16
10/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Honeywell (HON) downgraded to Buy from Conviction Buy at Goldman with analyst Christopher Glynn lowering his Q3 Earnings Per Share expectations for Honeywell after the company cut its earnings and revenue outlook and trimmed his price target to $122 from $128. 2. United Technologies (UTX) downgraded to Neutral from Buy at Citi with analyst Jason Gursky saying he sees three issues limiting share upside over the next twelve-plus months. 3. PNC Financial (PNC) was downgraded to Neutral from Buy at Nomura while the firm downgraded Fifth Third (FITB) to Reduce from Neutral. 4. Myriad Genetics (MYGN) downgraded to Sell from Neutral at Ladenburg with analyst Kevin DeGeeter citing a "significant and unexpected deterioration" in outlook for the company's companion diagnostic franchise. 5. HSN, Inc. (HSNI) downgraded to Hold from Buy at Craig-Hallum with analyst Alex Fuhrman saying his channel checks indicate continued weakness in the third quarter, with particular weakness in jewelry and consumer electronics. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

PKE

Park Electrochemical

$18.66

0.02 (0.11%)

06:31
06/28/17
06/28
06:31
06/28/17
06:31
Earnings
Park Electrochemical reports Q1 EPS before items 12c, consensus 13c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

CBI

CB&I

$20.02

5.62 (39.03%)

06:28
06/28/17
06/28
06:28
06/28/17
06:28
Recommendations
CB&I analyst commentary  »

Court ruling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

, TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

06:28
06/28/17
06/28
06:28
06/28/17
06:28
Periodicals
Toshiba to file $1B lawsuit against Western Digital, Reuters reports »

Toshiba (TOSBF, TOSYY)…

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

WDC

Western Digital

$91.85

-0.81 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KOP

Koppers Holdings

$34.00

-0.7 (-2.02%)

06:22
06/28/17
06/28
06:22
06/28/17
06:22
Upgrade
Koppers Holdings rating change  »

Koppers Holdings upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRB

H&R Block

$31.34

0.02 (0.06%)

06:18
06/28/17
06/28
06:18
06/28/17
06:18
Conference/Events
H&R Block management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

PFPT

Proofpoint

$84.48

-1.3 (-1.52%)

, SYMC

Symantec

$28.11

-0.75 (-2.60%)

06:18
06/28/17
06/28
06:18
06/28/17
06:18
Recommendations
Proofpoint, Symantec analyst commentary  »

Piper highlights…

PFPT

Proofpoint

$84.48

-1.3 (-1.52%)

SYMC

Symantec

$28.11

-0.75 (-2.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$34.48

0.1 (0.29%)

06:18
06/28/17
06/28
06:18
06/28/17
06:18
Conference/Events
Houlihan Lokey management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

HAL

Halliburton

$41.53

-0.17 (-0.41%)

06:17
06/28/17
06/28
06:17
06/28/17
06:17
Conference/Events
Halliburton management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 29

    Jun

  • 24

    Jul

FIVE

Five Below

$47.79

-0.545 (-1.13%)

06:16
06/28/17
06/28
06:16
06/28/17
06:16
Conference/Events
Five Below management to meet with Loop Capital »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

AABA

Altaba

$53.64

-0.67 (-1.23%)

, BABA

Alibaba

$141.53

-1.2 (-0.84%)

06:15
06/28/17
06/28
06:15
06/28/17
06:15
Initiation
Altaba, Alibaba, Yahoo Japan initiated  »

Altaba initiated with an…

AABA

Altaba

$53.64

-0.67 (-1.23%)

BABA

Alibaba

$141.53

-1.2 (-0.84%)

YAHOY

Yahoo Japan

$8.77

0.05 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

GIL

Gildan Activewear

$31.44

-0.3 (-0.95%)

06:08
06/28/17
06/28
06:08
06/28/17
06:08
Upgrade
Gildan Activewear rating change  »

Gildan Activewear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOV

Government Properties

$21.90

-0.425 (-1.90%)

06:07
06/28/17
06/28
06:07
06/28/17
06:07
Syndicate
Government Properties files to sell 25M shares of common stock »

The joint bookrunning…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRNT

Ceragon Networks

06:06
06/28/17
06/28
06:06
06/28/17
06:06
Hot Stocks
Ceragon Networks receives new orders from Tier 1 South Cone operator »

Ceragon Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jul

  • 13

    Jul

FDC

First Data

$18.53

-0.18 (-0.96%)

06:06
06/28/17
06/28
06:06
06/28/17
06:06
Downgrade
First Data rating change  »

First Data downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

EGOV

NIC Inc.

$19.00

-0.55 (-2.81%)

06:05
06/28/17
06/28
06:05
06/28/17
06:05
Initiation
NIC Inc. initiated  »

NIC Inc. initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPO

First Potomac

, GOV

Government Properties

$21.90

-0.425 (-1.90%)

06:02
06/28/17
06/28
06:02
06/28/17
06:02
Hot Stocks
First Potomac to be acquired by Government Properties in $1.4B deal »

First Potomac Realty…

FPO

First Potomac

GOV

Government Properties

$21.90

-0.425 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

06:01
06/28/17
06/28
06:01
06/28/17
06:01
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FPO

First Potomac

, GOV

Government Properties

$21.90

-0.425 (-1.90%)

06:00
06/28/17
06/28
06:00
06/28/17
06:00
Hot Stocks
Breaking Hot Stocks news story on First Potomac, Government Properties »

First Potomac to be…

FPO

First Potomac

GOV

Government Properties

$21.90

-0.425 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$21.13

-0.18 (-0.84%)

06:00
06/28/17
06/28
06:00
06/28/17
06:00
Syndicate
Canada Goose 12.5M share Secondary priced at $20.75 »

CIBC, Credit Suisse,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

RGEN

Repligen

$43.25

-2.09 (-4.61%)

05:59
06/28/17
06/28
05:59
06/28/17
05:59
Syndicate
Repligen 2.807M share Spot Secondary priced at $42.75 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

GDX

Market Vector Gold Miners

$22.26

-0.3 (-1.33%)

05:59
06/28/17
06/28
05:59
06/28/17
05:59
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$118.81

0.45 (0.38%)

05:59
06/28/17
06/28
05:59
06/28/17
05:59
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUGT

Direxion Gold Miners Bull

$31.50

-1.23 (-3.76%)

05:58
06/28/17
06/28
05:58
06/28/17
05:58
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYG

Tortoise Energy

$29.13

-0.14 (-0.48%)

05:58
06/28/17
06/28
05:58
06/28/17
05:58
Upgrade
Tortoise Energy rating change  »

Tortoise Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNUG

Direxion Daily Jr Gld Mnrs Bull 3X Shrs

$18.89

-0.46 (-2.38%)

05:58
06/28/17
06/28
05:58
06/28/17
05:58
Technical Analysis
Direxion Daily Jr Gld Mnrs Bull 3X Shrs: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.